Poll: How comfortable are you with including biosimilars in your treatment plans?

Vote in our most recent poll!

How comfortable are you with including biosimilars in your treatment plans?

A. Very excited to begin embracing biosimilars
B. Feeling comfortable exploring biosimilar options, though cautiously
C. Still hesitant, I need to learn more about biosimilars
D. With the knowledge of biosimilars I have, I am not comfortable including this in my treatment plans

RELATED: Introduction to biosimilars for AMD

Related Videos
Related Content

OCT biomarkers associated with advanced age-related macular degeneration

March 27th 2023

Open your eyes: ocular emergencies

January 17th 2022

Reversing the tides of AMD with drug targeting mitochondria to improve photopic vision

March 22nd 2023

Do diabetes, diabetic retinal disease contribute to macular degeneration?

March 21st 2023

Educating patients on refractive surgery options

March 20th 2023

This week in optometry: March 10-March 16

March 17th 2023

OCT biomarkers associated with advanced age-related macular degeneration

March 27th 2023

Open your eyes: ocular emergencies

January 17th 2022

Reversing the tides of AMD with drug targeting mitochondria to improve photopic vision

March 22nd 2023

Do diabetes, diabetic retinal disease contribute to macular degeneration?

March 21st 2023

Educating patients on refractive surgery options

March 20th 2023

This week in optometry: March 10-March 16

March 17th 2023

OCT biomarkers associated with advanced age-related macular degeneration

March 27th 2023

Open your eyes: ocular emergencies

January 17th 2022

Reversing the tides of AMD with drug targeting mitochondria to improve photopic vision

March 22nd 2023

Do diabetes, diabetic retinal disease contribute to macular degeneration?

March 21st 2023

Educating patients on refractive surgery options

March 20th 2023

This week in optometry: March 10-March 16

March 17th 2023
© 2023 MJH Life Sciences

All rights reserved.